Брзи Линкови
Q
Брзи Линкови
  2. International projects

International projects

List of international projects with the participation of the Faculty of Medicine Skopje

  1. TAIEX event 30751 – MK – TAIEX Workshop on Developing and unifying recommendations and guidelines for evaluation of complex DNA profiles of the forensic DNA experts in the Balkan region according to the international guidelines, in cooperation with the EU (2020).
  2. TAIEX event 30752 – MK – TAIEX Study Visit on Strengthening the knowledge of the DNA experts in the Republic of North Macedonia on the evaluation of complex DNA profiles according to the international guidelines, in cooperation with the EU (2020).
  3. “ Effectiveness of combining feedback about lung age or exhaled CO levels with very brief advice (VBA) and support for smoking cessation in primary care compared to giving VBA and support alone”. The project is led by the University of Birmingham – NIHR Global Health Research Group of Global COPD in Primary Care (2017-2020). Prof. Dr. Katerina Stavric is the principal investigator from the Faculty of Medicine in Skopje. (completed December 2021)
  4. “Uniform noting for international application of the tumor-stroma ratio as easy diagnostic tool-UNITED”. The project leader is the University Medical Center in Leiden, the Netherlands. Prof. Dr. Gordana Petrushevska is the principal investigator from the Faculty of Medicine in Skopje. (ongoing)
  5. “Expert support for development, adaptation of a training courses for immunization health professionals and managers in North Macedonia”. Project leader Prof. Dr. Katarina Stavric , in cooperation with the World Health Organization, 07 July – 20 December 2021. (completed December 2021)
  6. “Expert support for adaptation and implementation of training package “Communicating with patients about COVID-19 vaccination” Project leader Dr. Katerina Kovačević in cooperation with the World Health Organization. 20 August – 15 November 2021. (ongoing)
  7. “Family Doctors – Partners in expanding access and choice to contraception and sexual and reproductive health services”. Center for Family Medicine, Faculty of Medicine, Prof. Katarina Stavric is a partner in the project. Project leader HERA (HERA – Health Education and Research Association), 01.04.2020 – 31.09.2022. (ongoing)
  8. “Transferring simulation to medicine TRANSSIMED” Erasmus+ KA220-VET Cooperation partnerships in vocational education and training”. Project leader: Health Center Ljubljana Slovenia, partners: University of Zagreb, Health Center Zagreb-Centre Croatia and Center for Family Medicine Faculty of Medicine, University of St. Cyril and Methodius Skopje.
  9. “European general practitioners attitudes towards person-centered care and factors that influence its implementation in everyday practice”. Project leader Goranka Petriček, Department of Family Medicine, “Andrija Stampar” School of Public Health, School of Medicine, University of Zagreb, Health Centre Zagreb West, partners 22 European countries, Center for Family Medicine, Faculty of Medicine, University of St. Cyril and Methodius, Skopje (period September 2022-September 2023)
  10. “Implementation of protocols for reliable application of antibody testing in management of COVID-19 crisis”. Serbia , s Official Development Assistance (ODA) UNDP Serbia. Jan 2022 – March 2022. INSTITUT ZA PRIMENU NUKLEARNE ENERGIJE – INEP – dr Danica Ćujić, HEMIJSKI FAKULTET – Prof. dr Tanja Ćirković Veličković, INSTITUTE OF IMMUNOLOGY AND HUMAN GENETICS – Prof. Dr. Aleksandar Petličkovski.
  11. Project “Real-world effectiveness of COVID-19 vaccines in preventing symptomatic disease, hospitalization and death in the Macedonian population” Chinese Center for Disease Control and Prevention, Jan 2022-Jan 2023. Principal investigators: Aleksandar Petlichkovski, Feng Zijian.

International research projects and clinical studies at the Institute of Preclinical and Clinical Pharmacology with Toxicology:

  1. 1.”COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN / INDAPAMIDE MR 160 mg / 1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-702; CRO Study Code: LNI-268-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN / INDAPAMIDE MR 160 mg / 1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FED CONDITIONS”; (Sponsor Study Code: 21-714; CRO Study Code: LNI-269-21)
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER 4-WAY BIOAVAILABILITY STUDY OF EZETIMIBE/ATORVASTATIN 10 mg/ 80 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-711; CRO Study Code: ETA-230-21).
  1. Pharmacokinetic Characterization of benzydamine hydrochloride and cetylpyridinium chloride in Saliva after Single Dose of Septolete total lozenges (3 mg/1 mg) IN HEALTHY VOLUNTEERS; (Sponsor Study Code: 21-719; CRO Study Code: PES-340-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER, 4-WAY BIOAVAILABILITY STUDY EDOXABAN 60 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 21-715; CRO Study Code: ODE-288-21).
  1. “COMPARATIVE, SINGLE-DOSE, 3-WAY CROSSOVER BIOAVAILABILITY STUDY OF EMPAGLIFLOZIN 25 MG TABLET FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FED CONDITION”; (Sponsor Study Code: 21-701; CRO Study Code: PME-207-21).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF CANDESARTAN / INDAPAMIDE 16 MG / 2.5 MG”; (Sponsor Study Code: 22-724; CRO Study Code: NNI-27-22).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF POMALIDOMIDE 4 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITIONS”; (Sponsor Study Code: 22-725; CRO Study Code: MOP-28-22).
  1. “COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER BIOAVAILABILITY STUDY OF CANDESARTAN / INDAPAMIDE 16 MG / 2.5 MG”; (Sponsor Study Code: 22-734; CRO Study Code: BAD-66-22).
  1. “PHARMACOKINETIC INTERACTION STUDY BETWEEN TELMISARTAN 80 MG AND INDAPAMIDE SR 1.5 MG FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION”; (Sponsor Study Code: 21-699; CRO Study Code: LNI-168-22).
  1. “COMPARATIVE, RANDOMISED, MULTIPLE DOSE CROSSOVER BIOAVAILABILITY STUDY OF VALSARTAN/INDAPAMIDE MR 160 mg/1.5 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION”; (Sponsor Study Code: 22-742; CRO Study Code: LNI-199-22)”.
  1. ” COMPARATIVE, RANDOMISED, SINGLE-DOSE, CROSSOVER 2-WAY PILOT BIOEQUVALENCE STUDY OF TWO PARACETAMOL 500 mg FORMULATIONS IN HEALTHY VOLUNTEERS UNDER FASTING CONDITION “; (Sponsor Study Code: BEQPL-01-22; CRO Study Code: RAP-93-22).

International projects led by the Faculty of Medicine, funded by the Ministry of Education and Science and still ongoing:

“Inference and dynamic modeling of effective networks from neurological data: a comparison with structural and functional connectivity”, under the leadership of Assoc. Prof. Dr. Tomislav Stankovski, a Macedonian-Chinese project with the Institute of Science and Technology for Brain-inspired Intelligence (ISTBI), Fudan University, Shanghai, China (2020-2021).

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.